Early upregulation of AR and steroidogenesis enzyme expression after 3 months of androgen-deprivation therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2490
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Early upregulation of AR and steroidogenesis enzyme expression after 3 months of androgen-deprivation therapy ; volume:20 ; number:1 ; day:19 ; month:6 ; year:2020 ; pages:1-10 ; date:12.2020
BMC urology ; 20, Heft 1 (19.6.2020), 1-10, 12.2020
- Urheber
-
Hamid, Agus Rizal A. H.
Kusuma Putra, Harun W.
Sari, Ningrum Paramita
Diana, Putri
Sesari, Saras Serani
Novita, Eka
Gultom, Fajar Lamhot
Saraswati, Meilania
Tanurahardja, Budiana
Asmarinah
Umbas, Rainy
Mochtar, Chaidir A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12894-020-00627-0
- URN
-
urn:nbn:de:101:1-2020081621350341502606
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek.
Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hamid, Agus Rizal A. H.
- Kusuma Putra, Harun W.
- Sari, Ningrum Paramita
- Diana, Putri
- Sesari, Saras Serani
- Novita, Eka
- Gultom, Fajar Lamhot
- Saraswati, Meilania
- Tanurahardja, Budiana
- Asmarinah
- Umbas, Rainy
- Mochtar, Chaidir A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
PTP1B regulates lymphocytes responses androgen deprivation
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Androgen deprivation modulates the inflammatory response induced by irradiation
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Androgen deprivation in prostate cancer: benefits of home-based resistance training
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice
Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer
Enzyme der Estrogen- und Androgen-Biosynthese als Arzneistoff-Targets
PTP1B regulates lymphocytes responses androgen deprivation
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Androgen deprivation modulates the inflammatory response induced by irradiation
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Androgen deprivation in prostate cancer: benefits of home-based resistance training
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice
Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer
Enzyme der Estrogen- und Androgen-Biosynthese als Arzneistoff-Targets
PTP1B regulates lymphocytes responses androgen deprivation
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Androgen deprivation modulates the inflammatory response induced by irradiation
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Androgen deprivation in prostate cancer: benefits of home-based resistance training
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice
Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer